Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
424studies shown
Showing 385-396 of 424
Drug study icon
RecruitingNCT06229210

Safety and Tolerability study of Lumateperone in Pediatric people with Schizophrenia, Bipolarity or Autism Spectrum Disorder

This observational study is following people with Schizophrenia, bipolarity, or Autism Spectrum Disorder to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

Multiple locations, including Phoenix
Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, SchizophreniaDrugA study involving a medication or substance.From 5 Years to 17 Years
Countries
United States, Colombia, Serbia
Sponsor
Intra-Cellular Therapies, Inc.
Condition
Bipolarity, Schizophrenia
Drug study icon
RecruitingNCT05303064

Weight Gain for schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States, in Argentina, in Brazil, ...

Multiple locations, including Dothan
Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, SchizophreniaDrugFrom 10 Years to 17 Years
Countries
United States, Argentina, Brazil, ...
Sponsor
Alkermes, Inc.
Condition
Bipolarity, Schizophrenia
Behavioral study icon
RecruitingNCT04432116

Time and Virtual Reality in Schizophrenia and Bipolarity

This study is looking at care and outcomes for people with Schizophrenia or bipolarity. Taking part may give some people access to virtual reality 1, but direct benefit is not guaranteed.

In Strasbourg
Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, SchizophreniaBehavioralFrom 18 Years to 60 Years
Countries
France
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Condition
Bipolarity, Schizophrenia
Biological study icon
RecruitingEUCTR 2019-000256-33

A randomized, double-blinded, placebo-controlled study of Rituximab in patients with Psychosis and/or Obsessive Compulsive Disorder, with an indication of immune system involvement

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Uppsala
Why is this study shown?

This study includes Schizophrenia among several conditions.

OCD, SchizophreniaBiological
Countries
Sweden
Sponsor
Uppsala University Hospital
Condition
OCD, Schizophrenia
Drug study icon
RecruitingEUCTR 2021-004049-19

Sodium oxybate as a potential new treatment for catatonia in patients with depression, Bipolarity or a psychotic disorder, a randomized controlled trial. The Laborit study.

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Netherlands
Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, Depression, ...Drug
Countries
Netherlands
Sponsor
Amsterdam UMC
Condition
Bipolarity, Depression, ...
Behavioral study icon
RecruitingNCT06508450

A Mental Health Services Engagement Program for Racial and Ethnic Minority Young Adults

This study is looking at whether Just Do You can help people with Psychosis, bipolarity, or depression. Participants take part in the program and complete follow-up questionnaires or assessments.

In The Bronx
Why is this study shown?

This study includes Schizophrenia among several conditions.

Depression, Bipolarity, ...BehavioralFrom 18 Years to 34 Years
Countries
United States
Sponsor
New York University
Condition
Depression, Bipolarity, ...
Other study type icon
RecruitingNCT06856161

A Novel Blood Test as a Biomarker in Mental Health

This summary needs review. Please check the official study record and contact the research team for details.

In New Westminster
Why is this study shown?

This study includes Schizophrenia among several conditions.

Addiction, Depression, ...ObservationalA study where researchers collect information without assigning a treatment.Over 19 Years
Countries
Canada
Sponsor
Fraser Health
Condition
Addiction, Depression, ...
Device study icon
RecruitingNCT06005103

Randomized Clinical Trial Comparing Active Versus Sham T-PEMF Headband Treatment for depression

The registry lists this study as recruiting. Study locations are listed in Denmark.

In Frederiksberg
Why is this study shown?

This study includes Schizophrenia among several conditions.

Depression, SchizophreniaDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 65 Years
Countries
Denmark
Sponsor
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
Condition
Depression, Schizophrenia
Behavioral study icon
RecruitingNCT07359157

Changing Lives and Changing Outcomes-9 at Worcester Recovery Center and Hospital

This study is looking at whether a digital support tool can help people with Serious Mental Illness, psychosis, Depression, or Bipolar. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.

In Worcester
Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, Depression, ...BehavioralOver 18 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Bipolarity, Depression, ...
Behavioral study icon
RecruitingNCT06641726

Creating a Global Research Database That Connects Genetic Information and Long-term Health Data to Improve Personalized Treatment for People With Serious Mental Illness

The registry lists this study as recruiting. Study locations are listed in the United Kingdom.

In Oxford
Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, Depression, ...BehavioralFrom 18 Years to 110 Years
Countries
United Kingdom
Sponsor
Akrivia Health
Condition
Bipolarity, Depression, ...
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.